Healthcare Aug 10, 2020 01:45 PM (GMT+8) · EqualOcean
Jabrehoo, the auxiliary reproductive and genetic service provider in China, recently closed the Series B fundraising of up to CNY 100 million. The investment was exclusively led by GTJA Investment Group, a Shenzhen-based equity investor focusing on healthcare. Statistics show that the Chinese annual in vitro fertilization (IVF) has reached 900,000. More families are now more services from pre-pregnancy screening, infertility check to genetic testing and diagnosis. As the domestic pilot company that integrates Next Generation Sequencing (NGS) into Preimplantation Genetic Testing (PGT), the Beijing startup has tested over 180,000 embryo samples since the foundation in 2011.